71 related articles for article (PubMed ID: 11980658)
1. Expression of mitotic spindle checkpoint protein hsMAD1 correlates with cellular proliferation and is activated by a gain-of-function p53 mutant.
Iwanaga Y; Jeang KT
Cancer Res; 2002 May; 62(9):2618-24. PubMed ID: 11980658
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutants.
Yang X; Pater A; Tang SC
Oncogene; 1999 Aug; 18(32):4546-53. PubMed ID: 10467399
[TBL] [Abstract][Full Text] [Related]
3. Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity.
Notterman D; Young S; Wainger B; Levine AJ
Oncogene; 1998 Nov; 17(21):2743-51. PubMed ID: 9840938
[TBL] [Abstract][Full Text] [Related]
4. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
Li C; Lin M; Liu J
Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
[TBL] [Abstract][Full Text] [Related]
5. Characterization of regions in hsMAD1 needed for binding hsMAD2. A polymorphic change in an hsMAD1 leucine zipper affects MAD1-MAD2 interaction and spindle checkpoint function.
Iwanaga Y; Kasai T; Kibler K; Jeang KT
J Biol Chem; 2002 Aug; 277(34):31005-13. PubMed ID: 12042300
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy.
Vogel C; Kienitz A; Hofmann I; Müller R; Bastians H
Oncogene; 2004 Sep; 23(41):6845-53. PubMed ID: 15286707
[TBL] [Abstract][Full Text] [Related]
7. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
8. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
9. P130 and its truncated form mediate p53-induced cell cycle arrest in Rb(-/-) Saos2 cells.
Gao CF; Ren S; Wang J; Zhang SL; Jin F; Nakajima T; Ikeda M; Tsuchida N
Oncogene; 2002 Oct; 21(49):7569-79. PubMed ID: 12386819
[TBL] [Abstract][Full Text] [Related]
10. p31comet Induces cellular senescence through p21 accumulation and Mad2 disruption.
Yun M; Han YH; Yoon SH; Kim HY; Kim BY; Ju YJ; Kang CM; Jang SH; Chung HY; Lee SJ; Cho MH; Yoon G; Park GH; Kim SH; Lee KH
Mol Cancer Res; 2009 Mar; 7(3):371-82. PubMed ID: 19276188
[TBL] [Abstract][Full Text] [Related]
11. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
12. p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation.
Ha GH; Baek KH; Kim HS; Jeong SJ; Kim CM; McKeon F; Lee CW
Cancer Res; 2007 Aug; 67(15):7155-64. PubMed ID: 17671183
[TBL] [Abstract][Full Text] [Related]
13. MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells.
To-Ho KW; Cheung HW; Ling MT; Wong YC; Wang X
Oncogene; 2008 Jan; 27(3):347-57. PubMed ID: 17621272
[TBL] [Abstract][Full Text] [Related]
14. Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants.
Zalcenstein A; Stambolsky P; Weisz L; Müller M; Wallach D; Goncharov TM; Krammer PH; Rotter V; Oren M
Oncogene; 2003 Aug; 22(36):5667-76. PubMed ID: 12944915
[TBL] [Abstract][Full Text] [Related]
15. p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers.
Zhang DW; Jeang KT; Lee CG
Oncogene; 2006 Apr; 25(16):2318-27. PubMed ID: 16501612
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis.
Jeong SJ; Shin HJ; Kim SJ; Ha GH; Cho BI; Baek KH; Kim CM; Lee CW
Cancer Res; 2004 Dec; 64(23):8666-73. PubMed ID: 15574775
[TBL] [Abstract][Full Text] [Related]
17. Mitosis-independent survivin gene expression in vivo and regulation by p53.
Xia F; Altieri DC
Cancer Res; 2006 Apr; 66(7):3392-5. PubMed ID: 16585159
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
Kwon JA; Rho HM
Biol Chem; 2003 Feb; 384(2):203-12. PubMed ID: 12675512
[TBL] [Abstract][Full Text] [Related]
19. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW
J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242
[TBL] [Abstract][Full Text] [Related]
20. The farnesyltransferase inhibitor, FTI-2153, inhibits bipolar spindle formation during mitosis independently of transformation and Ras and p53 mutation status.
Crespo NC; Delarue F; Ohkanda J; Carrico D; Hamilton AD; Sebti SM
Cell Death Differ; 2002 Jul; 9(7):702-9. PubMed ID: 12058275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
